Lauren Tyler Acquires 550 Shares of Cencora (NYSE:COR) Stock

Cencora, Inc. (NYSE:COR) Director Lauren Tyler purchased 550 shares of the firm’s stock in a transaction on Monday, June 22nd. The stock was bought at an average price of $270.23 per share, for a total transaction of $148,626.50. Following the purchase, the director owned 4,359 shares in the company, valued at approximately $1,177,932.57. This represents a 14.44% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Cencora Price Performance

Shares of Cencora stock traded up $3.84 during trading on Wednesday, reaching $284.94. 1,633,370 shares of the stock traded hands, compared to its average volume of 1,543,568. The company has a market capitalization of $55.44 billion, a price-to-earnings ratio of 21.85, a P/E/G ratio of 1.46 and a beta of 0.59. The business has a fifty day simple moving average of $282.77 and a two-hundred day simple moving average of $323.17. The company has a debt-to-equity ratio of 3.40, a current ratio of 0.95 and a quick ratio of 0.59. Cencora, Inc. has a 52-week low of $244.82 and a 52-week high of $377.54.

Cencora (NYSE:COR) last issued its earnings results on Wednesday, May 6th. The company reported $4.75 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.82 by ($0.07). The firm had revenue of $78.36 billion during the quarter, compared to the consensus estimate of $81.09 billion. Cencora had a return on equity of 135.20% and a net margin of 0.78%.The company’s revenue for the quarter was up 3.9% compared to the same quarter last year. During the same period last year, the firm posted $4.42 earnings per share. Cencora has set its FY 2026 guidance at 17.650-17.900 EPS. Sell-side analysts expect that Cencora, Inc. will post 17.79 EPS for the current year.

Cencora Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Monday, June 1st. Shareholders of record on Friday, May 15th were paid a $0.60 dividend. The ex-dividend date of this dividend was Friday, May 15th. This represents a $2.40 dividend on an annualized basis and a yield of 0.8%. Cencora’s payout ratio is presently 18.40%.

Cencora announced that its Board of Directors has initiated a stock buyback program on Thursday, May 21st that permits the company to buyback $2.00 billion in outstanding shares. This buyback authorization permits the company to purchase up to 3.9% of its shares through open market purchases. Shares buyback programs are generally a sign that the company’s board of directors believes its shares are undervalued.

Analyst Ratings Changes

A number of equities research analysts recently issued reports on the stock. Wells Fargo & Company decreased their price target on shares of Cencora from $429.00 to $331.00 and set an “overweight” rating on the stock in a research note on Monday, May 11th. Barclays reduced their target price on shares of Cencora from $425.00 to $350.00 and set an “overweight” rating on the stock in a report on Wednesday, June 10th. William Blair assumed coverage on shares of Cencora in a report on Tuesday, April 28th. They issued a “market perform” rating for the company. Bank of America lifted their price target on Cencora from $280.00 to $285.00 and gave the stock a “neutral” rating in a research report on Wednesday. Finally, UBS Group boosted their price objective on Cencora from $410.00 to $412.00 and gave the stock a “buy” rating in a research note on Thursday, May 7th. Twelve analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $367.75.

Institutional Investors Weigh In On Cencora

Several hedge funds and other institutional investors have recently made changes to their positions in COR. Kemnay Advisory Services Inc. bought a new position in Cencora during the 4th quarter valued at about $25,000. Oakworth Capital Inc. bought a new stake in Cencora in the fourth quarter worth about $26,000. Elyxium Wealth LLC bought a new stake in Cencora in the fourth quarter worth about $27,000. Archer Investment Corp boosted its position in shares of Cencora by 134.3% during the fourth quarter. Archer Investment Corp now owns 82 shares of the company’s stock valued at $28,000 after buying an additional 47 shares during the period. Finally, Motiv8 Investments LLC bought a new position in shares of Cencora during the fourth quarter valued at approximately $29,000. Hedge funds and other institutional investors own 97.52% of the company’s stock.

About Cencora

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.